Angiocrine Bioscience
CA - San DiegoBiotechnology
Focus: Angiocrine Bioscience is a San Diego-based cellular therapy company focused on developing cell-based therapeutics for cancer and regenerative medicine indications. The company operates as a pre-revenue biotech with a pipeline spanning hematologic malignancies and orthopedic repair.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Angiocrine Bioscience
AI assessmentNot HiringNo open roles listed right now. Follow Angiocrine Bioscience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AB-110
Hematologic MalignanciesClinical Trials (1)
NCT03483324Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation
Phase 1Help build intelligence for Angiocrine Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.